2.1 Digital First Reports 2 and 3 We are seeking to engage with an external supplier to deliver two further Digital First reports. We want one report to focus on mobile health (also known as eHealth), and one on Pathology. Digital First Mobile Health (mHealth) 2.2 The ubiquity of mobile technology offers tremendous opportunities for the healthcare industry to address one of the most pressing global challenges: making healthcare more accessible, faster, better and cheaper. 2.3 By mHealth, we mean the provision of healthcare or health related information through the use of mobile devices (typically mobile phones, but also specialised medical devices, like wireless monitors). Mobile applications and service can include, amongst other things, remote patient monitors, video conferencing, online consultations and personal healthcare devcies. 2.4 The mHealth field operates on the premise that technology integration within the health sector has the great potential to promote a better health communication to achieve healthy lifestyles, improve decision-making by health professionals (and patients) and enhance healthcare quality by improving access to medical and health information and facilitating instantaneous communication in places where this was not previously possible. 2.5 Through the development of a report, we want to set out the benefits to primary and secondary care organisations on introducing low cost, low tech, patient/clinician initiatives like the Florence text messaging service for people with long term conditions. Developed in the NHS, it enables patients to take responsibility for the monitoring and management of their condition and when to seek treatment. There are other initiatives such as Health2works, Health Fabric and Cloud2, that we are aware of, as well as potentially many others. Amongst other things, for example, interactive web tools can enhance self care, eliminate unnecessary bureaucracy and face to face visits and give patients far better service experiences. We would expect the successful organisation to research all the initiatives currently in operation across the NHS, and set out the associated benefits (evidence and cost based analysis) for each. Digital First Pathology 2.6 We believe, through discussions with stakeholders, that a 'Digital First Pathology' report will help to motivate and surpass the shift that was required, but hasn't been achieved, under Quality Innovation Productivity and Prevention of Â£500m in savings. 2.7 Pathology testing touches over 2/3 of all clinical engagement and costs about Â£2bn annually. The impact on clinical services is almost double that, thus a modest improvement in pathology could have considerable savings downstream through effective, high quality and integrated care delivery. 2.8 We see such a report presenting a clear message to commissioners to focus on the service Pathology can provide in end-to-end scenarios, rather than focusing purely on the commissioning of batches of tests in volumes. 2.9 Creating a report with sound clinical input would embrace the pathology community and perhaps strengthen the case for Digital First (and it's brand) and have a more relevant impact than that produced for the first Digital First report. 2.10 To that effect pathology leaders have already been looking at the types of improvements required to make this viable: â€¢ The use of "results triage services" for GPs to help them identify suitable follow-up care for patients in terms of referrals, further testing or treatment. Such initiatives will reduce inefficiencies in the number of inappropriate tests carried out as well as inappropriate clinic sessions for patients; â€¢ He also considers how the uptake of public health screening programmes could be made more effective, again looking at the triage of test outcomes to identify the correct sequence of follow-up activity; â€¢ Yorkshire have been researching the use of an a non-geographic eConsultation tool for renal patients - using an electronic clinic which allows the GP to access the patient's records and provide real-time support and care instruction, reducing inappropriate primary and secondary service utilisation. For renal, the data suggests that renal clinics could be reduced by 50%; â€¢ Within the GP primary care sector, of the 100 million test 'transactions' that occur annually, 50% are for ongoing monitoring of known conditions, chronic disease etc. These are often disconnected processes across multiple channels, which communicate passively with patients, e.g. "You're results are fine, see you in 6-12 months for your next test." This process/cycle could be leveraged for more effective care engagement with patients to improve their health and reduce their impact on services.
Contract value: 70000.00 - 90000.00GBP
Published: 3 Jan 2013, Receipt by: 8 Mar 2013
All suppliers that are registered with us receive email notifications of Public Sector tenders related to their area of business.